Search
Search titles only
By:
Search titles only
By:
Log in
Register
Search
Search titles only
By:
Search titles only
By:
Menu
Install the app
Install
Forums
New posts
All threads
Latest threads
New posts
Trending threads
Trending
Search forums
What's new
New posts
New ads
New profile posts
Latest activity
Free Ads
Latest reviews
Search ads
Members
Current visitors
New profile posts
Search profile posts
Contact us
Latest ads
Ad icon
Video Content Creator
pramukag
Updated:
Today at 6:10 AM
Ad icon
QA Engineer Intern
pramukag
Updated:
Today at 6:07 AM
Ad icon
Sell your Land, House on idamata.lk for FREE
sajith.xp.pk
Updated:
Thursday at 9:03 AM
Handmade Character Soft Toys
anil1961
Updated:
Tuesday at 2:11 PM
Bodim.lk out now !
Manoj Suranga Bandara
Updated:
Jun 21, 2026
Electronics
Vehicles
Property
Search
Reply to thread
Forums
General
ElaKiri Talk!
NB.1.8.1 Variant
Get the App
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="imhotep" data-source="post: 30770885" data-attributes="member: 562115"><p>The World Health Organization (WHO) Technical Advisory Group on Virus Evolution (TAG-VE) on May 23 announced that it has designated NB.1.8.1 as a SARS-CoV-2 variant under monitoring (VUM), noting that, although proportions are growing rapidly, the virus seems only marginally more immune-evasive than the more dominant LP.8.1 sublineage.</p><p></p><p>The experts said NB.1.8.1 is fueling rises in cases and hospitalization in some countries in the WHO Western Pacific region, but there are no reports that illnesses are more severe than those from other circulating variants.</p><p></p><p>NB.1.8.1 clusters with other JN.1 sublineages and descends from XDV.1.5.1. The earliest sample was collected on January 22. So far sequences have been submitted from 22 countries.</p><p></p><p>NB.1.8.1 stems from the Omicron XDV recombinant lineage. Recombinant variants arise when two or more COVID strains merge and exchange genetic material, often resulting in a virus with unique properties.</p><p></p><p><strong>NB.1.8.1 carries several mutations in its spike protein, including T22N, F59S, G184S, A435S, V445H, and T478I. These changes may improve the virus’s ability to bind to the human ACE2 receptor, making infection more efficient.</strong></p><p></p><p>Preliminary lab-based studies suggest NB.1.8.1 has the strongest binding affinity to human cells among recent variants tested. This means it might be<strong> easier to catch and spread than its predecessors.</strong></p><p>Early research indicates that while <strong>antibody neutralisation is reduced</strong>—by roughly 1.5 times—against NB.1.8.1 when compared to the LP.8.1.1 variant, COVID-19 vaccines are still effective at preventing severe illness.</p><p></p><p><strong>There is currently no evidence that NB.1.8.1 leads to more severe disease outcomes compared to other strains. However, its increased transmissibility and partial immune evasion are causing concern.</strong></p><p><strong>One of the most notable concerns about NB.1.8.1 is that it appears to <strong>spread more easily</strong> and could potentially <strong>bypass immune protection</strong> from previous infections or vaccinations.</strong></p><p></p><p>Vietnam reported recently that 83% of patients in Hi Chin Minh city tested positive for NB.1.8.1 with Thailand reporting over 250,000 cases. <img class="smilie smilie--emoji" loading="lazy" alt="🙁" title="Slightly frowning face :slight_frown:" src="https://cdn.jsdelivr.net/joypixels/assets/6.6/png/unicode/64/1f641.png" data-shortname=":slight_frown:" /> If you are travelling take care. No reason to panic though.</p><p></p><p><a href="https://imgbox.com/cRSDbILW" target="_blank"><img src="https://thumbs2.imgbox.com/71/16/cRSDbILW_t.jpg" alt="" class="fr-fic fr-dii fr-draggable " style="" /></a></p></blockquote><p></p>
[QUOTE="imhotep, post: 30770885, member: 562115"] The World Health Organization (WHO) Technical Advisory Group on Virus Evolution (TAG-VE) on May 23 announced that it has designated NB.1.8.1 as a SARS-CoV-2 variant under monitoring (VUM), noting that, although proportions are growing rapidly, the virus seems only marginally more immune-evasive than the more dominant LP.8.1 sublineage. The experts said NB.1.8.1 is fueling rises in cases and hospitalization in some countries in the WHO Western Pacific region, but there are no reports that illnesses are more severe than those from other circulating variants. NB.1.8.1 clusters with other JN.1 sublineages and descends from XDV.1.5.1. The earliest sample was collected on January 22. So far sequences have been submitted from 22 countries. NB.1.8.1 stems from the Omicron XDV recombinant lineage. Recombinant variants arise when two or more COVID strains merge and exchange genetic material, often resulting in a virus with unique properties. [B]NB.1.8.1 carries several mutations in its spike protein, including T22N, F59S, G184S, A435S, V445H, and T478I. These changes may improve the virus’s ability to bind to the human ACE2 receptor, making infection more efficient.[/B] Preliminary lab-based studies suggest NB.1.8.1 has the strongest binding affinity to human cells among recent variants tested. This means it might be[B] easier to catch and spread than its predecessors.[/B] Early research indicates that while [B]antibody neutralisation is reduced[/B]—by roughly 1.5 times—against NB.1.8.1 when compared to the LP.8.1.1 variant, COVID-19 vaccines are still effective at preventing severe illness. [B]There is currently no evidence that NB.1.8.1 leads to more severe disease outcomes compared to other strains. However, its increased transmissibility and partial immune evasion are causing concern. One of the most notable concerns about NB.1.8.1 is that it appears to [B]spread more easily[/B] and could potentially [B]bypass immune protection[/B] from previous infections or vaccinations.[/B] Vietnam reported recently that 83% of patients in Hi Chin Minh city tested positive for NB.1.8.1 with Thailand reporting over 250,000 cases. 🙁 If you are travelling take care. No reason to panic though. [URL='https://imgbox.com/cRSDbILW'][IMG]https://thumbs2.imgbox.com/71/16/cRSDbILW_t.jpg[/IMG][/URL] [/QUOTE]
Insert quotes…
Verification
Awruddata maasa keeyada?
Post reply
Top
Bottom